<DOC>
	<DOCNO>NCT01473108</DOCNO>
	<brief_summary>Pharmacodynamics , pharmacokinetics , safety , tolerability investigate single dose study . In 5 treatment group , different dosage BAY94-8862 give healthy male subject .</brief_summary>
	<brief_title>Study Investigate Natriuretic Effects , Safety , Tolerability Pharmacokinetics BAY94-8862</brief_title>
	<detailed_description>Clinical pharmacology</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Fludrocortisone</mesh_term>
	<criteria>Healthy male white subject 18 46 year age Body mass index ( BMI ) : 18 29.9 kg/mÂ² Clinically relevant finding medical history physical examination Systolic blood pressure 100 140 mmHg Diastolic blood pressure 50 90 mmHg Heart rate 45 95 beat / min</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>46 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Healthy volunteer , proof-of-concept trial , PK PD</keyword>
</DOC>